Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
To augment vitamin B12 intake in those who have a partial or total removal of the stomach or intestine
Key Clinical Trial Results Phase 2 NASH trial (NEJM, 2021): In a 72-week, double-blind trial of patients with biopsy-confirmed NASH and fibrosis stages F1-F3, daily subcutaneous semaglutide at 0.4 mg achieved NASH resolution without worsening of fibrosis in 59% of patients compared to 17% on placebo
Please note: If you're feeling unwell on the day, please contact us to reschedule
PMID: 16034940
US$ 24.61
US$ 22.38
US$ 29.22
US$ 24.10
US$ 21.75
US$ 21.49
US$ 21.72
